Pharmacokinetics and Safety of Ertapenem in the Postpartum Period

Summary

The investigators are doing this study to learn more about the dosing and safety of ertapenem in women with suspected serious infections less than 42 days from the delivery of their infant.

Timeline

Start

2012-03

Primary completion

2014-01

Completion

2014-01

Drugs

Indications